Previously, it has been demonstrated that TRPV2 expression correlates with worse OS and PFS for triple negative breast cancer [13], esophageal squamous cell carcinoma [46], MM [47] and gastric cancer [48]. This evidence concerns the gene TRPV2 and esophageal squamous cell carcinoma.